Jiri Presl

8PUBLICATIONS
29CO-AUTHORS
Gene and molecular therapyObstetrics and gynaecologyPredictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Diagnostic radiography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 25, 2026
Immunoreactivity of GPNMB (glycoprotein nonmetastatic melanoma protein B) across the spectrum of uterine mesenchymal tumours.

|Mar 17, 2026
Robotic interposition of the mesorectum during low anterior resection of the rectum for endometriosis using tissue perfusion assessment with indocyanine green.

Vladimír Baláž, Vladimír Teplan, Kamila Benková

|Jan 23, 2026
The influence of selected immunohistochemical and clinical-pathological markers on the prognosis of patients with malignant uterine tumors.

Petra Herboltová, Petra Ovesná, Klára Dvořáková

|Jul 15, 2025
Possible use of indocyanine green in the management of endometriosis.

Vladimír Baláž, Martin Syrůček, Jiří Presl

|Nov 13, 2024
Advantages of next-generation sequencing (NGS) in the molecular classifi cation of endometrial carcinomas - our experience with 270 cases.

Květoslava Michalová, Jiří Presl, Andrea Straková-Peteříková

|Nov 09, 2024
The Role of HE4 in the Follow-Up of Advanced Ovarian, Fallopian Tube, and Primary Peritoneal Cancer-CEEGOG OX-01 Study.

Jiri Presl, Pavel Havelka, Vit Weinberger

Pageof 2

Frequent Collaborators

2 joint publications

Vladimír Baláž

2 joint publications

Michal Michal

2 joint publications

Marián Švajdler

2 joint publications

Květoslava Michalová